Key result
Hypoalbuminemia was associated with significantly higher long-term mortality compared to normal serum albumin levels in patients with UAP or NSTEMI (32% vs 8.6%; P<.001).
Why the study?
Long-term mortality remains high in patients with UAP or NSTEMI despite treatment improvements, and the prognostic utility of serum albumin was unclear.
Does on-admission hypoalbuminemia predict long-term mortality in patients hospitalized with UAP/NSTEMI?
Cohort (n=403)
Does on-admission hypoalbuminemia predict long-term mortality in patients hospitalized with UAP/NSTEMI?
Absolute Event Rate: 32% vs 8.6%
p-value: p=<.001
On-admission hypoalbuminemia is a strong, independent predictor of long-term all-cause mortality in patients presenting with UAP or NSTEMI.
No takes yet. Share an insight, caveat, or question.
Hypoalbuminemia identifies high-risk patients for closer monitoring; leaves open whether correction improves survival.
Polat et al. (2020) conducted a cohort in Unstable angina pectoris (UAP) or non-ST elevation myocardial infarction (NSTEMI) (n=403). Hypoalbuminemia vs. Normal serum albumin levels was evaluated on Long-term mortality (p=<.001). Hypoalbuminemia was associated with significantly higher long-term mortality compared to normal serum albumin levels in patients with UAP or NSTEMI (32% vs 8.6%; P<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: